203 related articles for article (PubMed ID: 3315448)
1. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
2. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
4. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive treatment with guanfacine in patients with type II diabetes mellitus].
Coves MJ; Gomis R; Goday A; Casamitjana R; Rivera F; Vilardell E
Med Clin (Barc); 1987 Feb; 88(8):315-7. PubMed ID: 3550310
[No Abstract] [Full Text] [Related]
7. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
8. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
10. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
12. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
13. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
14. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
Dupont AG; Vanderniepen P; Six RO
Bibl Cardiol; 1987; (42):161-7. PubMed ID: 3307757
[No Abstract] [Full Text] [Related]
17. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
Mayer K; Lupínek Z; Janousek S; Podrouzková B
Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
[No Abstract] [Full Text] [Related]
18. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
19. [Clinical pharmacology of the antihypertensive action of guanfacine].
Safar M; Weiss Y; Georges D
Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
[TBL] [Abstract][Full Text] [Related]
20. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
